Avalo Therapeutics Price Chart
Avalo Therapeutics Volume Chart
Avalo Therapeutics Market Segments
After Hours
*No Trades in Segment
Regular Trading Hours
-0.55(-3.95%)
| Open | $13.94 |
|---|---|
| Close | $13.39 |
| Low | $13.19 |
| Low Change | -0.76 (-5.42%) |
| High | $14.80 |
| High Change | +0.86 (+6.17%) |
| Range | $1.62 |
| Volume | 398.319K |
| Dollar Volume | $5.33M |
Premarket
-0.08(-0.56%)
| Open | $14.29 |
|---|---|
| Close | $14.21 |
| Low | $14.21 |
| Low Change | -0.08 (-0.56%) |
| High | $14.29 |
| High Change | +0.00 (+0.00%) |
| Range | $0.08 |
| Volume | 202 |
| Dollar Volume | $2.87K |
After Hours Yesterday
*No Trades in Segment
Regular Trading Hours Yesterday
-0.55(-3.95%)
| Open | $13.94 |
|---|---|
| Close | $13.39 |
| Low | $13.19 |
| Low Change | -0.76 (-5.42%) |
| High | $14.80 |
| High Change | +0.86 (+6.17%) |
| Range | $1.62 |
| Volume | 398.319K |
| Dollar Volume | $5.33M |
Premarket Yesterday
-0.08(-0.56%)
| Open | $14.29 |
|---|---|
| Close | $14.21 |
| Low | $14.21 |
| Low Change | -0.08 (-0.56%) |
| High | $14.29 |
| High Change | +0.00 (+0.00%) |
| Range | $0.08 |
| Volume | 202 |
| Dollar Volume | $2.87K |
Avalo Therapeutics Moving Averages
| 5 Day Moving Average (SMA5) | $15.20 |
|---|---|
| 10 Day Moving Average (SMA10) | $16.13 |
| 20 Day Moving Average (SMA20) | $16.57 |
| 50 Day Moving Average (SMA50) | $15.88 |
| 100 Day Moving Average (SMA100) | $16.74 |
| 200 Day Moving Average (SMA200) | $12.72 |
Avalo Therapeutics Statistics
| Average Volume (30 Days) | 539.9K |
|---|---|
| P/E Ratio (Current) | -2.72 |
| EPS (Current) | -$5.39 |
| Dividend Yield | 0.00% |
| Free Cash Flow | — |
| Cash Ratio | 3.38 |
| Current Ratio | 14.27 |
| Quick Ratio | 14.27 |
| Debt to Equity | 0.00 |
| Enterprise Value | $244.80M |
| EV to EBITDA | -3.70 |
| EV to Sales | 1275.02 |
| Price to Book | 2.97 |
| Price to Cash Flow | — |
| Price to Free Cash Flow | — |
| Price to Sales | 1415.45 |
| Return on Assets | -0.80% |
| Return on Equity | -1.09% |
Avalo Therapeutics Stock Splits
There have been 3 stock splits for Avalo Therapeutics (AVTX). The last reverse stock split occured on December 29, 2023 and reduced the outstanding shares at a ratio of 240:1.
| Date | Type | Ratio |
|---|---|---|
| Dec 29, 2023 | Reverse | 240:1 |
| Jul 8, 2022 | Reverse | 12:1 |
| Sep 10, 2007 | Reverse | 51:1 |
Avalo Therapeutics Dividends
There have been no dividends for Avalo Therapeutics (AVTX).